Kazia Therapeutics

KZIA

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Value held

$704k

Combined value at quarter end

Last quarter

1 bought

0 sold or trimmed

Price at Q2 ’26 end

$14.08

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Managers holding it, by quarter

0Q4 ’23

0Q1 ’24

0Q2 ’24

0Q3 ’24

0Q4 ’24

0Q1 ’25

0Q2 ’25

0Q3 ’25

0Q4 ’25

0Q1 ’26

1Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes Kazia Therapeutics.

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Kazia Therapeutics

Omega Family Office (Leon Cooperman)	0.0%$704k	$704k	New	1 qtr

Download the holders: CSV · JSON · Markdown